




Jennifer L. Patnaik,* Heath Harmon,† 
and Richard L. Vogt*
Tri-County Health Department and Boulder County
Public Health conducted a follow-up study of all nonfatal
West Nile virus (WNV) cases reported during 2003 in 4
metropolitan Denver, Colorado, counties. Self-reported
patient information was obtained ≈6 months after onset. A
total of 656 (81.2%) eligible WNV patients are included in
this study.
I
n 2003, Colorado experienced a large West Nile virus
(WNV) epidemic, which accounted for 29.9% of the
nation’s 9,862 reported WNV infections (1). Tri-County
Health Department, which serves Adams, Arapahoe, and
Douglas counties, and Boulder County Public Health col-
laborated to conduct a follow-up study of all WNV cases
reported in these 4 counties in 2003. We conducted this
follow-up study with 3 objectives: 1) to identify potential
risk factors for developing neuroinvasive disease, 2) to
describe the symptoms of patients 6 months after onset,
and 3) to describe healthcare utilization and impact on
daily activities associated with all types of WNV infection.
The Study
Since 2002, healthcare providers and laboratories have
been required to report patients with laboratory evidence
of acute WNV infection in Colorado. Patients were includ-
ed in this study if WNV-specific immunoglobulin M (IgM)
antibodies were found in either cerebrospinal fluid (CSF)
or serum by enzyme-linked immunosorbent assay, or
symptoms later developed in blood donors with a positive
nucleic acid test result. In addition to laboratory confirma-
tion, patients had to meet one of the following case defini-
tions to be included in the study: 1) encephalitis cases
required a physician’s diagnosis and clinical manifestation
of encephalitis, including mental status changes, delirium,
disorientation, or coma; 2) meningitis cases required a
physician’s diagnosis or clinical exhibition of meningitis
and abnormal CSF findings consistent with viral meningi-
tis; and 3) fever cases required mild to moderate illness
without clinical or laboratory evidence of central nervous
system involvement. A compatible illness of WNV fever
was defined as symptoms consisting of >2 of the following
occurring within 90 days of testing: fever, headache, chills,
myalgia, arthralgia, rash, lymphadenopathy, muscle weak-
ness, or severe malaise. Any patient with a positive IgM
test result on CSF was considered to have neuroinvasive
disease.
Self-reported patient information was solicited through
a standardized survey sent to 808 patients with nonfatal
cases. Cases of meningitis and encephalitis were compared
with cases of WNV fever. Measures of association between
diagnosis and relevant patient characteristics were deter-
mined by Wald χ2, odds ratios, and associated 95% confi-
dence intervals for categorical variables and analysis of
variance (ANOVA) testing for continuous variables.
Multivariate logistic regression modeling was used to test
for potential predictors of more severe disease at time of
diagnosis. Variables were considered significant at the p =
0.05 level. Data were entered into EpiInfo 2002 (available
from www.cdc.gov/epiinfo/) and analyzed with SAS ver-
sion 9.1 software (SAS Institute, Inc., Cary, NC, USA).
A total of 656 (81.2%) patients completed the survey:
52.1% were female, 42.8% were >50 years of age, 80.9%
had a diagnosis of fever, 12.8% had a diagnosis of menin-
gitis, and 6.3% had a diagnosis of encephalitis. Nineteen
cases were detected through blood donor screening, and all
were categorized as uncomplicated fever cases.
Nonrespondents were less likely to be female (42.1%, p =
0.0259) and >50 years of age (27.6%, p = 0.0007) but were
similar by diagnosis category (p = 0.5846).
Mean ages by diagnosis were 60 years for encephalitis
patients, 48 years for meningitis patients, and 46 years for
fever patients. Encephalitis patients were significantly
older than meningitis and fever patients (p<0.0001). The
median period between onset of illness and completion of
the follow-up survey was 178 days (range 102–299 days);
80% responded within 5–7 months after illness onset.
The overall prevalences of several chronic conditions
and treatments are shown in Table 1. After adjustment for
sex and age >50 years, encephalitis patients were signifi-
cantly more likely than fever patients to report having sev-
eral chronic conditions and to report having been on
chemotherapy. Meningitis patients were more likely than
fever patients to report having cancer and to have under-
gone chemotherapy.
Symptom duration was reported as >3 months for
48.7% of encephalitis patients, 26.2% of meningitis
patients, and 20.3% of fever patients (Table 2). Muscle
weakness and muscular pain at time of follow-up were
reported by more than one third of encephalitis patients
(Table 3). No notable differences in symptoms were
reported based on the difference in the interval between
onset date and date of completing the follow-up survey.
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among encephalitis (97.6%) and meningitis (91.7%)
patients than fever patients (13.9%). The mean length of
stay for all hospitalized patients was 11 days (range 1–165
days) and was significantly higher for encephalitis patients
(20 days) than meningitis patients (10 days) and fever
patients (7 days). Significantly more encephalitis and men-
ingitis patients sought physical therapy (65.9% and 34.9%,
respectively), occupational therapy (50.0% and 18.3%,
respectively), and speech therapy (30.8% and 10.8%,
respectively) than fever patients. Among fever patients,
6.6% reported receiving at least 1 of the 3 therapies.
Missing time from work was reported by most all cate-
gories of cases. For the 485 patients who were working at
the time of illness onset, encephalitis patients and meningi-
tis patients were significantly more likely to report missing
work (100.0% and 98.3%, respectively) than fever patients
(78.9%). The median number of work days missed was sig-
nificantly higher among encephalitis patients (65 days) and
meningitis patients (51 days) than fever patients (16 days).
In addition, 91.0% of all patients reported that their routine
daily activities were prevented by their WNV infection.
Conclusions
This study characterizes the severe impact that WNV
infection had on all age groups and categories of WNV ill-
ness in a defined population-based cohort of 656 nonfatal
infections. Our study results corroborated findings from
previous studies that older age is predictive of more severe
WNV illness, such as encephalitis (2–4) and death (2,4–7).
In our study, the mean age of meningitis patients did not
differ significantly from that of fever patients.
Additionally, we identified several preexisting medical
conditions, as well as prior utilization of chemotherapy,
that may predispose infected persons to the development
of encephalitis or meningitis. The risk for encephalitis has
been found to be higher among organ transplant recipients
(8); however, the literature is inconsistent regarding
whether preexisting medical conditions are predictive of
neuroinvasive disease (2,4,7,9). The studies that did not
detect such associations used different comparison groups
than did our study and were limited by small sample size
or low prevalence of these chronic medical conditions.
Only 1 other study has characterized the clinical spec-
trum of symptom duration among West Nile fever patients
and missed work or school days (10). This study of 98
fever patients found that 39% had ongoing symptoms after
an average of almost 6 months of follow-up, 82% reported
limitations in household activities, and a median number
of 10 missed work or school days (10). Our fever patients
reported a higher number of missed work or school days
with a median of 16. Additional studies with objective
measures could better elucidate the long-lasting effects of
WNV infection.
Because of the nature of self-reported data, both recall
bias and misclassification of self-reported information are
potential limitations of this study. However, we validated
self-reporting of definitive fields such as sex and hospital-
ization because they were highly correlated with the initial
data maintained in our statewide surveillance database.
Another limitation of our study was that a clinical diag-
nosis of flaccid paralysis or lack thereof was not confirmed
in study cases. Estimated rates of flaccid paralysis are low
(2,11) and therefore should not have had a large impact on
our study findings. In addition, patients who had died were
excluded from the study; therefore, we were not able to
characterize this group for preexisting chronic conditions.
Our study was limited to reported case-patients who
DISPATCHES
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our findings likely represent the more severe spectrum of
infections.
Our study demonstrates that WNV infection caused
considerable, long-lasting, severe illness during the 2003
Colorado epidemic and that the economic impact in terms
of associated healthcare utilization and days of missed
work was substantial. Public health officials should inten-
sify prevention messages to help limit the severe manifes-
tations of WNV infection and especially target those at
greatest risk for severe disease.
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